Clinical Trial Update: ID HBV Vaccination With Imiquimod in OBI [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating hepatitis B vaccination with imiquimod has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: The University of Hong Kong | Conditions: Hepatitis B | Phase 2, Phase 3 | Status: COMPLETED